Literature DB >> 8593488

Effects of repeated cold stress on aversive responses produced by intrathecal excitatory amino acids in rats.

K Okano1, Y Kuraishi, M Satoh.   

Abstract

We previously demonstrated the involvement of spinal glutamatergic system in repeated cold stress (RCS)-induced hyperalgesia. In the present experiments, to estimate the involvement of an enhancement of responsiveness to endogenously released glutamate in RCS-induced hyperalgesia, we examined the effects of RCS on behavioral nociceptive responses (biting or licking the hind paws and the tail) produced by intrathecal injections of selective agonists at subtypes of glutamate receptor, N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) and kainate, in rats. The exposure of rats to RCS significantly intensified the behavioral responses produced by intrathecal NMDA (1 nmol/rat) in comparison to the control rats. The increase in the behavioral response of the RCS rats to AMPA was significant at a dose of 1 nmol/rat of AMPA as compared to the control rats. A significant increase in aversive response over control rats was not seen when kainate (0.3--nmol/rat) was injected into the spinal subarachnoid space of the RCS rats. These results suggest that RCS induces an enhancement of transmission mediated by endogenously released glutamate through NMDA and non-NMDA (especially AMPA) receptors in the spinal dorsal horn.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8593488     DOI: 10.1248/bpb.18.1602

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

Review 1.  Glutamate receptors and nociception: implications for the drug treatment of pain.

Authors:  M E Fundytus
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

2.  Intrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia.

Authors:  Alice A Larson; Myra G Nunez; Casey L Kissel; Katalin J Kovács
Journal:  Eur J Neurosci       Date:  2015-10-09       Impact factor: 3.386

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.